PHILADELPHIA, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it has commenced a shareholder investigation into BioAtla, Inc. (NASDAQ: BCAB) on behalf of the company’s investors.

Since February 2023, shares of BioAtla’s common stock have declined in value from a trading price of over $4.30 per share to a current trading price of less than $2.50 per share, a decline of over 41% in value.

The investigation seeks to determine whether BioAtla and/or the company’s officers and directors violated the securities laws or breached their fiduciary duties to the company’s shareholders.

BioAtla shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 – 0750, or by email (skaskela@kaskelalaw.com / abell@kaskelalaw.com) or online at https://kaskelalaw.com/cases/bioatla/ , for additional information about this investigation and their legal rights and options.

Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation on a contingent basis, and has aided in the recovery of over $250 million for defrauded investors since 2020. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.

CONTACT:

KASKELA LAW LLC
D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 – 1740
(484) 229 – 0750
www.kaskelalaw.com

This notice may constitute attorney advertising in certain jurisdictions.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.